Trial Profile
A Randomised Double Blind Placebo Controlled Clinical Trial of Centchroman (Saheli) in breast pain and nodularity (Benign Breast Disorders).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Centchroman (Primary)
- Indications Breast disorders; Breast pain
- Focus Therapeutic Use
- 02 Sep 2010 Actual initiation date changed from 10 Oct 2007 to 20 Dec 2008 as reported by ClinicalTrials.gov.
- 05 Aug 2010 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 02 Jul 2009 New trial record